Long term evaluation of etiological treatment of Chagas disease with benznidazole
Top Cited Papers
Open Access
- 1 February 2002
- journal article
- clinical trial
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 44 (1) , 29-37
- https://doi.org/10.1590/s0036-46652002000100006
Abstract
The aim of this article is to present an investigation of cure rate, after long follow up, of specific chemotherapy with benznidazole in patients with both acute and chronic Chagas disease, applying quantitative conventional serological tests as the base of the criterion of cure. Twenty one patients with the acute form and 113 with one or other of the various chronic clinical forms of the disease were evaluated, after a follow up period of 13 to 21 years, for the acute, and 6 to 18 years, for the chronic patients. The duration of the acute as well as the chronic disease, a condition which influences the results of the treatment, was determined. The therapeutic schedule was presented, with emphasis on the correlation between adverse reactions and the total dose of 18 grams, approximately, as well as taking into consideration precautions to assure the safety of the treatment. Quantitative serological reactions consisting of complement fixation, indirect immunofluorescence, indirect hemagglutination, and, occasionally, ELISA, were used. Cure was found in 76 per cent of the acute patients but only in 8 per cent of those with chronic forms of the disease. In the light of such contrasting results, fundamentals of the etiological therapy of Chagas disease were discussed, like the criterion of cure, the pathogenesis and the role of immunosuppression showing tissue parasitism in long standing chronic disease, in support of the concept that post-therapeutic consistently positive serological reactions mean the presence of the parasite in the patient's tissues. In relation to the life-cycle of T. cruzi in vertebrate host, there are still some obscure and controversial points, though there is no proof of the existence of resistant or latent forms. However, the finding over the last 15 years, that immunosuppression brings about the reappearance of acute disease in long stand chronic patients justifies a revision of the matter. Facts were quoted in favor of the treatment of chronic patients.Keywords
This publication has 31 references indexed in Scilit:
- Immunological and Clinical Evaluation of Chagasic Patients Subjected to Chemotherapy during the Acute Phase ofTrypanosoma cruziInfection 14–30 Years AgoThe Journal of Infectious Diseases, 2000
- In chronic chagas heart disease, don't forget the parasiteParasitology Today, 1996
- Parasitism of adipocytes by Trypanosoma cruziMemórias do Instituto Oswaldo Cruz, 1995
- Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- Effect of specific chemotherapy on the levels of lytic antibodies in Chagas's diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- MICROPLATE ENZYME-LINKED IMMUNOSORBENT ASSAY FOR CHAGAS' DISEASEThe Lancet, 1975
- Biology of Trypanosoma CruziAnnual Review of Microbiology, 1973
- The Detection of Chagas' Disease:Vox Sanguinis, 1970
- Chagas' DiseaseCirculation, 1956
- THE ADSORPTION OF PROTEINS ON ERYTHROCYTES TREATED WITH TANNIC ACID AND SUBSEQUENT HEMAGGLUTINATION BY ANTIPROTEIN SERAThe Journal of Experimental Medicine, 1951